We are live on
!
Find out more
VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
191 hedge funds and large institutions have $3.19B invested in Verona Pharma in 2024 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 57 increasing their positions, 59 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
27% more funds holding
Funds holding: 150 → 191 (+41)
0.07% more ownership
Funds ownership: 10.41% → 10.48% (+0.07%)
3% less repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 59
Holders
191
Holding in Top 10
23
Calls
$71.2M
Puts
$16.7M
Top Buyers
| 1 | +$71.4M | |
| 2 | +$68.4M | |
| 3 | +$43M | |
| 4 |
Morgan Stanley
New York
|
+$33.5M |
| 5 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$30.4M |
Top Sellers
| 1 | -$122M | |
| 2 | -$87.5M | |
| 3 | -$47.5M | |
| 4 |
OCA
Octagon Capital Advisors
New York
|
-$47.5M |
| 5 |
MC
Maverick Capital
Dallas,
Texas
|
-$40.8M |